Literature DB >> 16300812

Regeneration of the replication-associated proteins tandem direct repeat recognition nucleotide sequence at the origin of DNA replication of porcine circovirus type 1.

Andrew K Cheung1.   

Abstract

Four copies of a hexanucleotide (H) sequence are located to the right of the palindrome at the origin of DNA replication of the porcine circovirus type 1 (PCV1) genome. These sequences are organized in two direct tandems, the proximal H1/H2 and the distal H3/H4 repeats, and they have been shown to be binding sites for the essential Rep and Rep' proteins. Previous work demonstrated that infectious PCV1 virion can accommodate a variable number of H sequences at the origin of DNA replication. In this work, mutational analysis was conducted to elucidate the critical core element within the hexanucleotide with respect to self-DNA replication and progeny virus synthesis. It was found that while a single H sequence abutting the palindrome is sufficient for PCV1 viability, a tandem repeat arrangement is the more stable and thus preferred configuration. Within the H sequence, selected nucleotides at specific positions are critical for Rep-associated protein recognition and for viral DNA replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300812     DOI: 10.1016/j.virol.2005.10.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  Rolling-circle replication of an animal circovirus genome in a theta-replicating bacterial plasmid in Escherichia coli.

Authors:  Andrew K Cheung
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Novel canine circovirus strains from Thailand: Evidence for genetic recombination.

Authors:  Chutchai Piewbang; Wendy K Jo; Christina Puff; Erhard van der Vries; Sawang Kesdangsakonwut; Anudep Rungsipipat; Jochen Kruppa; Klaus Jung; Wolfgang Baumgärtner; Somporn Techangamsuwan; Martin Ludlow; Albert D M E Osterhaus
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.